Can a weight-loss medication actually cure your deepest cravings? Discover how GLP-1 drugs are revolutionizing the landscape of addiction recovery.
Find mental health and addiction treatment near you: https://recovery.com/
In this episode of Recoverable, host Terry Maguire sits down with Dr. Steven Klein, an expert medical professional specializing in addiction medicine who also brings his own powerful lived experience of nine years in long-term recovery. Together, they explore the fascinating science of drug repurposing—shifting medications like semaglutide and tirzepatide (widely known under brand names like Ozempic, Wegovy, Mounjaro, and Zepbound) from type 2 diabetes and chronic weight management over to the frontlines of substance use disorder treatment. Dr. Klein breaks down how these powerful gut-brain peptides quiet persistent "food noise" and "drug noise" by directly targeting the mesolimbic dopamine system, which controls the brain’s fundamental reward circuitry.
Whether discussing alcohol use disorder, opioid use disorder, nicotine dependence, or behavioral addictions like compulsive gambling, this deep-dive addresses the critical neurobiology behind how GLP-1 for addiction functions as a substance-agnostic tool. You’ll learn about recent groundbreaking clinical data showing a 50% drop in substance-related mortality, the clinical reality of off-label prescribing, common GI side effects, and what happens to internal cravings once you stop taking the medication. Dr. Klein shares his profound "record needle" analogy, showing how these treatments temporarily quiet internal noise so individuals can learn a completely new behavioral song. If you or a loved one are exploring cutting-edge medical tools to support sustainable recovery, reduce relapse, and reclaim your agency, this episode provides essential context, breaking down the artificial boundaries between physical metabolic health and mental health.
Watch the full conversation to unlock the future of highly personalized behavioral care. Don't forget to like this video, subscribe to the channel, and share your thoughts or personal experiences in the comments section below!
Chapters: 00:00 – Intro 01:14 – How GLP-1s Transformed My Relationship with Food 06:27 – How Weight Loss Drugs Ended Up on the Addiction Radar 09:05 – How GLP-1s Treat the Core Circuitry of Addiction 11:14 – What Are the Side Effects of GLP-1 Medications? 15:18 – How Do GLP-1 Drugs Actually Work for Addiction? 18:00 – Does Brain Rewiring Continue After Stopping GLP-1s? 23:49 – Are GLP-1s FDA-Approved for Addiction Treatment? 26:53 – Do GLP-1s Cause Anhedonia or Suicidal Thoughts? 42:31 – Can You Take GLP-1s for Addiction Without Losing Weight?
Questions the Video Answers:
How do GLP-1 drugs work for addiction treatment?
Can Ozempic or Wegovy help reduce alcohol cravings?
What is the success rate of GLP-1 medications for substance use disorders?
How do diabetes and weight-loss drugs quiet food noise in the brain?
Are GLP-1 medications FDA-approved to treat alcohol or opioid addiction?
What are the common side effects of using GLP-1s for addiction recovery?
Do cravings return after you stop taking semaglutide or tirzepatide?
Can you take GLP-1 medications for addiction if you don't want to lose weight?
How do GLP-1 agonists impact the brain's dopamine reward system?
Is it safe to combine GLP-1s with other addiction medications like buprenorphine?
Will health insurance cover Ozempic or Zepbound if prescribed off-label for addiction?
Can GLP-1 medications help treat behavioral addictions like gambling or sex addiction?
What did the British Medical Journal study find regarding GLP-1s and substance mortality?
Does taking weight-loss drugs cause anhedonia or a general loss of joy?
How long will it take for the FDA to approve GLP-1s for addiction?
#GLP1ForAddiction #OzempicForAddiction #AddictionRecovery